"10.1371_journal.pone.0056278","plos one","2013-02-13T00:00:00Z","Katy-Anne Thompson; John V Pappachan; Allan M Bennett; Himanshu Mittal; Susan Macken; Brian K Dove; Jonathan S Nguyen-Van-Tam; Vicky R Copley; Sarah O’Brien; Peter Hoffman; Simon Parks; Andrew Bentley; Barbara Isalska; Gail Thomson; EASE Study Consortium","Biosafety Investigation Unit, Health Protection Agency, Porton Down, Wiltshire, United Kingdom; Paediatric Intensive Care Unit, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom; Biosafety Investigation Unit, Health Protection Agency, Colindale, London, United Kingdom; Influenza Group, Health Protection Agency, Porton Down, Wiltshire, United Kingdom; Health Protection and Influenza Research Group, University of Nottingham, Nottingham, United Kingdom; Microbial Risk Assessment Group, Health Protection Agency, Porton Down, Wiltshire, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; Antimicrobial Resistance and Healthcare-Associated Reference Unit, Health Protection Agency, Colindale, London, United Kingdom; Acute Intensive Care Unit, University Hospital of South Manchester, Wythenshawe, Manchester, United Kingdom; Department of Microbiology, University Hospital of South Manchester, Wythenshawe, Manchester, United Kingdom; Medical Affairs, Health Protection Agency, Porton Down, Wiltshire, United Kingdom","Conceived and designed the experiments: GT AB KAT JP JVT SP PH BD. Performed the experiments: KAT BD HM SM. Analyzed the data: VC KAT JP AB JVT SO PH AB BI GT. Contributed reagents/materials/analysis tools: BD. Wrote the paper: KAT JP AB BD JVT VC SO PH AB BI GT.","KAT, BD, SM, SP, JP, GT, VC, HM, SO, PH, AB and BI have no conflict of interest. JVT: The University of Nottingham Health Protection Research Group is currently in receipt of research funds from GlaxoSmithKline plc (GSK), who are manufacturers/distributors of a virucidal respirator; this research funding is entirely unrelated to the performance or use of the virucidal respirator. Furthermore the research funding from GSK did not support any aspect of the work described in this manuscript. JVT has also received consultancy fees from GSK; but all forms of personal remuneration ceased in September, 2010. JVT is a former employee of SmithKline Beecham plc. (now GSK) prior to 2002, with no outstanding pecuniary interests in GSK by way of shareholdings, share options or accrued pension rights. This does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.","2013","02","Katy-Anne Thompson","KAT",15,TRUE,8,4,9,10,TRUE,TRUE,TRUE,1,"15",TRUE
